If You or a Loved One Has Been Injured Due to Avandia – Take Action Now!
*** Avandia® Labeling Update 2/4/11: The FDA has notified healthcare professionals and patients that information on the cardiovascular risks (including heart attack) of Avandia (rosiglitazone) has been added to the physician labeling and patient Medication Guide. Additionally, the drug labels have been revised to state that rosiglitazone and rosiglitazone-containing medicines should only be used:
- In patients already being treated with these medicines
- In patients whose blood sugar cannot be controlled with other anti-diabetic medicines and who, after consulting with their healthcare professional, do not wish to use pioglitazone-containing medicines (Actos, Actoplus Met, Actoplus Met XR, or Duetact).
What’s the problem?
Avandia (Rosiglitazone) medication may cause or worsen certain heart problems such as congestive heart failure and heart attack. Seek immediate medical attention if you notice any symptoms of heart problems including: swelling of hands/feet, unusual/sudden weight gain; trouble breathing; chest pain/discomfort.
High Risk Patients
Those with the highest risk of developing serious, potentially life-threatening Avandia side effects include patients who have a history of:
- Congestive heart failure
- High blood pressure (hypertension)
- Blood clots and / or deep vein thrombosis (DVT)
- Heart disease
- Heart attack
Additionally, Avandia patients taking the following medications will also have an elevated risk of developing serious health problems while taking Avandia:
- Thyroid medication
- Nitrate drugs
- Rifampin (Rifater, Rifadin, Rimactane)
- Gemfibrozil (Gemcor)